Behavior Enhances Drug Reduction of Incontinence (BE-DRI) (BE-DRI)

Clinical Trial ID NCT00090584

PubWeight™ 12.40^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00090584

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial.	Ann Intern Med	2008	1.68
2	Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors.	Phys Ther	2010	1.62
3	Mixed incontinence: comparing definitions in non-surgical patients.	Neurourol Urodyn	2011	1.46
4	Design of the Behavior Enhances Drug Reduction of Incontinence (BE-DRI) study.	Contemp Clin Trials	2006	1.15
5	Minimum important difference for validated instruments in women with urge incontinence.	Neurourol Urodyn	2011	1.01
6	Associated factors and the impact of fecal incontinence in women with urge urinary incontinence: from the Urinary Incontinence Treatment Network's Behavior Enhances Drug Reduction of Incontinence study.	Am J Obstet Gynecol	2009	0.97
7	Predictors of outcomes in the treatment of urge urinary incontinence in women.	Int Urogynecol J Pelvic Floor Dysfunct	2009	0.85
8	Correlates and predictors of patient satisfaction with drug therapy and combined drug therapy and behavioral training for urgency urinary incontinence in women.	Int Urogynecol J	2010	0.81
9	Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women.	BJU Int	2009	0.80
10	The effects of drug and behavior therapy on urgency and voiding frequency.	Int Urogynecol J	2010	0.76
11	Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy.	Int Urogynecol J Pelvic Floor Dysfunct	2008	0.75
12	Patient expectations did not predict outcome of drug and behavioral treatment of urgency urinary incontinence.	Female Pelvic Med Reconstr Surg	2011	0.75